 | |
| Clinical data | |
|---|---|
| Other names | TH-FEA; 2-(2-Tetrahydrofuryl)ethylamine; 2-Aminoethyltetrahydrofuran; Tetrahydrofurfurylmethylamine |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.252.264 |
| Chemical and physical data | |
| Formula | C6H13NO |
| Molar mass | 115.176 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
2-Tetrahydrofurylethylamine (TH-FEA or2-(2-tetrahydrofuryl)ethylamine) is adrug related to thearylalkylamines.[1]Analogues include2-furylethylamine (FEA),2-pyrrolylethylamine (NEA),β-phenethylamine,amphetamine, andthiopropamine, among others.[1] A fewderivatives of TH-FEA are known.[1] The compound ispharmacologically active, producing a strong constricting effect on theuterus.[1][2] TH-FEA was first described in thescientific literature by 1920.[1]
 | Thispharmacology-related article is astub. You can help Wikipedia byexpanding it. |